VE
LIVE

Serial Number

79438380

Owner

MAGVIR s.r.l.

Attorney

Bruce Margulies

Filing Date

Aug 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

VE Trademark

Serial Number: 79438380

VE is a trademark filed by MAGVIR s.r.l. on August 25, 2025. The trademark is classified under Class 1 (Chemicals). The application is currently pending registration.

Owner Contact Info

MAGVIR s.r.l.

Piazza della Vittoria, 7/14

Entity Type: 16

Trademark Details

Filing Date

August 25, 2025

Registration Date

Not Registered

Published for Opposition

September 29, 2026

Goods & Services

Chemical compounds, namely, raw materials for use in the manufacture of cosmetics and pharmaceuticals, namely, ACS-Anticytostressor, Adf-Oleile, Afron-22, Afrosalt, Alcoramnosan, Alutrat, Aminoefaderma-20 N-P, Arrectosina, Auxina Tricogena, Azamide, Braxicina N-P, Carbossalina, Cellosan, Cetacene, Cetasol-Velvet, Collagenon, Dacriosalt, Daucoil N-P, Dermonectin, Delta Rosa Moschata, Desadrops, Efaderma, Efaderma-F, Efadermasterolo, Elicrisina, Epch, Fenexol, Filagrinol, Frabes-Oil Dcg, Hexatrate, Hexatrate Al-F, Hyaluramine-S, Hydrofarv, Idroramnosan, Integrine-60, Iodotrat, Ipbs-F, Isocet, Isostearene, Isoxal-1, Isoxal-12, Isoxal-H, Ixol-2, Ixol-4, Ixol-6, Ixol-8, Ixolene-2, Ixolene-4, Ixolene-6, Ixolene-8, Kalixide Grassa, Kalixide-As, Kalixide Ct, Keratoplast, Keresine P-E, Lanolide, Lanolide-Extra, Lanolide-F5, Lipocerite, Lipofarv, Lipogelag, Lipophos, Liporamnosan, Lipotrophyne-A, Liquiritina, Lmb, Megasol 3d, Megasol E-Sink, Megasol M-Mod, Melibion, Myristamine, Nesatol, Nidaba-318, Nidaba-S, Octaprotein-Colloid, Oligoidyne-1-Complex, Oligoidyne-2-Complex, Osmopherine, Osmopherone-H, Osmopherone-L, Phytosqual, Phytosqual Hydrogen, Pme, Pme-1 N-P, Poliglicoleum, Poliglicoleum-G, Poliglicoleum-N, Ricino-Viscoil-N, Salycuminol, Sebopessina, Seboside, Sitostene, Skyline-F, Skyline-P, Syntesqual, Talcoseptic-C, Tensoil-N, Tergene-12, Thalaton, Thalaton P-F, Tricosolfan, Trilipidina, Trioxene-Lv, Undamide, Undebenzofene-C, Undebenzofene-C P-F, Undebenzofene-Hp, Undelene, Undenat, Undezin, Vaselide, Viscolene, Visonoil-R, Vyox, Vyox-G, Xalidrene, Xalifin-15, Xalifin-15 N-P, Zedomine-1-L, Zedomine-2-L, Zedomine-3-L, Hydroessentials, Lipoplastidines; Surfactants for use in the manufacture of cosmetic finished products; Emulsifiers for use in the manufacture of cosmetic finished products; Fats and oils for use in the manufacture of cosmetic finished products; Rheologic Additives for use in manufacture of cosmetic finished products; Antioxidants for use in manufacture of cosmetic finished products; antioxidants for use in the manufacture of cosmetics; Preservatives for use in manufacture of cosmetic finished products; preservatives for use in the pharmaceutical industry; Inorganic and Metallorganic active chemical ingredients for use in manufacture of cosmetic finished products; iodine for chemical purposes; iodised salts for use in manufacture of cosmetic finished products; plant-derived active chemical ingredients for use in manufacture of cosmetic finished products; plant extracts for use in the manufacture of cosmetics; essential oils for use in manufacture; active chemical ingredients for use in manufacture of cosmetic finished products; Active chemical ingredients for use in manufacture of finished cosmetic products.

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 2, 2026 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Aug 19, 2026 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Aug 19, 2026 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Aug 19, 2026 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 14, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 14, 2026 GNFN
FINAL REFUSAL E-MAILED
May 14, 2026 GNFR
FINAL REFUSAL WRITTEN
May 14, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 6, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 6, 2026 TROA
REFUSAL PROCESSED BY IB
Feb 19, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 5, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 5, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 11, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 10, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 8, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 15, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 15, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 4, 2025 REPR